Glenmark Life Sciences Limited (GLS.BO)

INR 1021.7

(-0.42%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 28.5 Billion 27.02 Billion 24.71 Billion 19.97 Billion 17.25 Billion 14.75 Billion
Total Current Assets 19.15 Billion 18.5 Billion 17.64 Billion 13.99 Billion 11.6 Billion 9.3 Billion
Cash And Short Term Investments 3.91 Billion 3.27 Billion 5.17 Billion 1.39 Billion 307.68 Million 78.48 Million
Cash and Cash Equivalents 3.01 Billion 2.83 Billion 5.12 Billion 1.15 Billion 99.98 Million 20.61 Million
Short Term Investments 905.48 Million 440.12 Million 51.46 Million 241.64 Million 207.7 Million 57.87 Million
Net Receivables 7.65 Billion 8.91 Billion 7.2 Billion 7.51 Billion 7.28 Billion 5.23 Billion
Inventory 6.66 Billion 6.04 Billion 5.16 Billion 5.13 Billion 4.12 Billion 4 Billion
Other Current Assets 920.14 Million 591.01 Million 567.84 Million 9.42 Million 3.35 Million -13.35 Million
Total Non-Current Assets 9.34 Billion 8.51 Billion 7.06 Billion 5.98 Billion 5.65 Billion 5.44 Billion
Net PPE 8.96 Billion 8.24 Billion 6.76 Billion 5.78 Billion 5.49 Billion 5.3 Billion
Good Will And Intangible Assets 148.53 Million 180.01 Million 103.8 Million 79.11 Million 71.68 Million 63.51 Million
Good Will - - - - - -
Intangible Assets 148.53 Million 180.01 Million 103.8 Million 79.11 Million 71.68 Million 63.51 Million
Long-Term Investments -794.41 Million 770 Thousand 770 Thousand 770 Thousand 770 Thousand 770 Thousand
Tax Assets 942.2 Million 18.12 Million 10.74 Million 20.26 Million 1.31 Million 22.85 Million
Other Non Current Assets 85.84 Million 76.74 Million 185.56 Million 90.34 Million 83.06 Million 56.86 Million
Other Assets - - - 0.00 - -
Total Liabilities 5.18 Billion 5.63 Billion 4.16 Billion 12.44 Billion 13.23 Billion 13.87 Billion
Total Current Liabilities 4.38 Billion 5.04 Billion 3.83 Billion 12.21 Billion 13.07 Billion 13.8 Billion
Account Payables 3.68 Billion 4.09 Billion 3.24 Billion 2.22 Billion 2.03 Billion 1.87 Billion
Tax Payables - 70.78 Million 120.03 Million 136.93 Million 83.6 Million 23.54 Million
Short Term Debt 23.87 Million 22.65 Million 16.8 Million 124.03 Million 210 Thousand 210 Thousand
Deferred Revenue 523.02 Million 19.43 Million 11.26 Million 72.9 Million 54.1 Million 28.28 Million
Other Current Liabilities 154.23 Million 907.08 Million 567.86 Million 9.79 Billion 10.98 Billion 11.9 Billion
Total Non Current Liabilities 793.17 Million 595.26 Million 326.99 Million 228.88 Million 164.48 Million 68.56 Million
Long-Term Debt 147.61 Million 170.92 Million 12.04 Million - - -
Deferred Revenue Non Current - -424.34 Million -314.95 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 157.71 Million 424.34 Million 314.95 Million - - -
Other Liabilities - - - - - -
Total Equity 23.32 Billion 21.38 Billion 20.54 Billion 7.52 Billion 4.01 Billion 881.25 Million
Stock Holders Equity 23.32 Billion 21.38 Billion 20.54 Billion 7.52 Billion 4.01 Billion 881.25 Million
Common Stock 245.05 Million 245.05 Million 245.05 Million 19.6 Million 19.6 Million 19.6 Million
Retained Earnings 12.91 Billion 11.02 Billion 10.21 Billion 7.5 Billion 3.99 Billion 861.65 Million
Accumulated other comprehensive income 23.07 Billion 10.29 Billion 10.29 Billion 19.6 Million 19.6 Million 19.6 Million
Common Stock Equity 23.32 Billion 21.38 Billion 20.54 Billion 7.52 Billion 4.01 Billion 881.25 Million
Capital Lease Obligation 171.48 Million 193.57 Million 28.84 Million - - -
Total Investments 111.07 Million 770 Thousand 770 Thousand 770 Thousand 770 Thousand 770 Thousand
Total Debt 171.48 Million 193.57 Million 28.84 Million 9.32 Billion 210 Thousand 210 Thousand
Net Debt -2.84 Billion -2.64 Billion -5.09 Billion 8.17 Billion -99.77 Million -20.4 Million

Balance Sheet Charts